Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance
Background As a leading cause of chronic kidney disease, clinical demand for noninvasive biomarkers of diabetic kidney disease (DKD) beyond proteinuria is increasing. Metabolomics is a popular method to identify mechanisms and biomarkers. We investigated urinary targeted metabolomics in DKD patients...
Main Authors: | Soie Kwon, Jin Seong Hyeon, Youngae Jung, Lilin Li, Jung Nam An, Yong Chul Kim, Seung Hee Yang, Tammy Kim, Dong Ki Kim, Chun Soo Lim, Geum-Sook Hwang, Jung Pyo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2023-07-01
|
Series: | Kidney Research and Clinical Practice |
Subjects: | |
Online Access: | http://www.krcp-ksn.org/upload/pdf/j-krcp-22-152.pdf |
Similar Items
-
Myo-inositol in the treatment of male factor infertility
by: Evgenia V. Shikh, et al.
Published: (2022-09-01) -
The Kidney Specific Protein myo-Inositol Oxygenase, a Potential Biomarker for Diabetic Nephropathy
by: Peng Gao, et al.
Published: (2018-11-01) -
Myo-Inositol as a Key Supporter of Fertility and Physiological Gestation
by: Riccardo Gambioli, et al.
Published: (2021-05-01) -
Myo- inositol and its metabolites in abiotic stress tolerance in plants
by: Raksha Mukhia, et al.
Published: (2022-12-01) -
Nonlipid myo-inositol derivatives: preparation and biomedical applications
by: A. E. Stepanov, et al.
Published: (2011-04-01)